Bio Essence Corporation
BIOE
$0.206
-$0.008-3.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 147.60K | 134.70K | 41.70K | -- | -205.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 147.60K | 134.70K | 41.70K | -- | -205.10K |
| Cost of Revenue | 40.70K | 53.70K | 12.50K | -- | -- |
| Gross Profit | 106.90K | 81.00K | 29.20K | -- | -- |
| SG&A Expenses | 103.00K | 227.40K | 194.20K | 151.80K | -382.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 49.30K | -- | -- |
| Total Operating Expenses | 143.70K | 281.10K | 256.00K | 151.80K | -667.90K |
| Operating Income | 3.90K | -146.40K | -214.30K | -151.80K | 252.60K |
| Income Before Tax | -27.60K | -1.20M | -214.90K | -123.00K | 216.20K |
| Income Tax Expenses | 0.00 | -- | 800.00 | -- | -1.60K |
| Earnings from Continuing Operations | -27.60K | -1.20M | -215.70K | -123.00K | 217.80K |
| Earnings from Discontinued Operations | 0.00 | -- | -- | 256.90K | -411.50K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.60K | -1.20M | -215.70K | 133.90K | -193.70K |
| EBIT | 3.90K | -146.40K | -214.30K | -151.80K | 252.60K |
| EBITDA | 4.10K | -146.40K | -214.00K | -151.30K | 222.30K |
| EPS Basic | 0.00 | -0.03 | -0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.03 | -0.01 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 38.01M | 38.01M | 38.01M | 38.01M | 33.95M |
| Average Diluted Shares Outstanding | 38.01M | 38.01M | 38.01M | 38.01M | 33.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |